280 related articles for article (PubMed ID: 19348960)
1. Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics?
Hajishengallis G
Microbes Infect; 2009; 11(6-7):637-45. PubMed ID: 19348960
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic microbes and community service through manipulation of innate immunity.
Hajishengallis G; Krauss JL; Liang S; McIntosh ML; Lambris JD
Adv Exp Med Biol; 2012; 946():69-85. PubMed ID: 21948363
[TBL] [Abstract][Full Text] [Related]
3. Porphyromonas gingivalis: major periodontopathic pathogen overview.
Mysak J; Podzimek S; Sommerova P; Lyuya-Mi Y; Bartova J; Janatova T; Prochazkova J; Duskova J
J Immunol Res; 2014; 2014():476068. PubMed ID: 24741603
[TBL] [Abstract][Full Text] [Related]
4. The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay.
Yilmaz Ö
Microbiology (Reading); 2008 Oct; 154(Pt 10):2897-2903. PubMed ID: 18832296
[TBL] [Abstract][Full Text] [Related]
5. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
6. Distinct gene expression characteristics in epithelial cell-
Zhang D; Hou J; Wu Y; Liu Y; Li R; Xu T; Liu J; Pan Y
Int J Med Sci; 2019; 16(10):1320-1327. PubMed ID: 31692996
[No Abstract] [Full Text] [Related]
7. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis.
Cutler CW; Kalmar JR; Genco CA
Trends Microbiol; 1995 Feb; 3(2):45-51. PubMed ID: 7728384
[TBL] [Abstract][Full Text] [Related]
8. Fetal Weight Outcomes in C57BL/6J and C57BL/6NCrl Mice after Oral Colonization with
Fischer LA; Bittner-Eddy PD; Costalonga M
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331955
[No Abstract] [Full Text] [Related]
9. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
10. Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant.
Yagishita H; Kumagai Y; Konishi K; Takahashi Y; Aoba T; Yoshikawa M
Infect Immun; 2001 Nov; 69(11):7159-61. PubMed ID: 11598093
[TBL] [Abstract][Full Text] [Related]
11. Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages.
Wang M; Shakhatreh MA; James D; Liang S; Nishiyama S; Yoshimura F; Demuth DR; Hajishengallis G
J Immunol; 2007 Aug; 179(4):2349-58. PubMed ID: 17675496
[TBL] [Abstract][Full Text] [Related]
12. LuxS signaling in Porphyromonas gingivalis-host interactions.
Scheres N; Lamont RJ; Crielaard W; Krom BP
Anaerobe; 2015 Oct; 35(Pt A):3-9. PubMed ID: 25434960
[TBL] [Abstract][Full Text] [Related]
13. The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model.
Wilensky A; Polak D; Houri-Haddad Y; Shapira L
J Clin Periodontol; 2013 Oct; 40(10):924-32. PubMed ID: 23909600
[TBL] [Abstract][Full Text] [Related]
14. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence.
Singh A; Wyant T; Anaya-Bergman C; Aduse-Opoku J; Brunner J; Laine ML; Curtis MA; Lewis JP
Infect Immun; 2011 Nov; 79(11):4533-42. PubMed ID: 21911459
[TBL] [Abstract][Full Text] [Related]
15. Converging findings from linkage between periodontal pathogen with atopic and allergic immune response.
Nelwan SC; Nugraha RA; Endaryanto A; Meizarini A; Tedjosasongko U; Pradopo S; Utomo H
Cytokine; 2019 Jan; 113():89-98. PubMed ID: 29937409
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model.
Gibson FC; Gonzalez DA; Wong J; Genco CA
Infect Immun; 2004 Apr; 72(4):2408-11. PubMed ID: 15039370
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipid-Containing Outer Membrane Vesicles Serve as a Delivery Vehicle To Limit Macrophage Immune Response to Porphyromonas gingivalis.
Rocha FG; Ottenberg G; Eure ZG; Davey ME; Gibson FC
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33361202
[TBL] [Abstract][Full Text] [Related]
18.
Liu S; Zhou X; Peng X; Li M; Ren B; Cheng G; Cheng L
J Immunol; 2020 Jul; 205(1):282-289. PubMed ID: 32471882
[TBL] [Abstract][Full Text] [Related]
19. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis.
Lamont RJ; Jenkinson HF
Microbiol Mol Biol Rev; 1998 Dec; 62(4):1244-63. PubMed ID: 9841671
[TBL] [Abstract][Full Text] [Related]
20. Role of Porphyromonas gingivalis HmuY in Immunopathogenesis of Chronic Periodontitis.
Carvalho-Filho PC; Gomes-Filho IS; Meyer R; Olczak T; Xavier MT; Trindade SC
Mediators Inflamm; 2016; 2016():7465852. PubMed ID: 27403039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
